Deuterated Paraxanthine for Reduced Side Effects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current formulations of paraxanthine often result in undesirable side effects such as anxiety, insomnia, gastrointestinal issues, and addiction, and require frequent administration, which can lead to reduced patient compliance.
Innovation Solution
Development of compositions comprising deuterated paraxanthine, which replaces hydrogen atoms with deuterium, offering reduced side effects and potentially longer duration of action, allowing for less frequent administration and improved patient compliance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If paraxanthine is administered at conventional doses and frequencies, then central nervous system stimulation is achieved, but undesirable side effects such as anxiety, insomnia, gastrointestinal issues, and addiction occur
Solution Approach 1:
The patent applies parameter changes by deuterating the paraxanthine molecule, specifically replacing hydrogen atoms with deuterium at specific positions (methyl groups). This isotopic modification changes the physical and chemical parameters of the drug, resulting in improved pharmacokinetics and reduced side effects while maintaining therapeutic efficacy. The deuterated version exhibits reduced anxiety, insomnia, and gastrointestinal issues compared to conventional paraxanthine.
2Duration of action of moving object
If paraxanthine is administered frequently to maintain therapeutic effect, then central nervous system stimulation is sustained, but patient compliance is reduced due to frequent administration requirements
Solution Approach 1:
The deuterium substitution at the methyl groups of paraxanthine modifies the molecular weight and bond strength parameters, leading to extended duration of action. The C-D bonds are stronger and more stable than C-H bonds, resulting in slower metabolic degradation and prolonged pharmacological activity. This allows for less frequent dosing intervals, thereby improving patient compliance while maintaining therapeutic effect.
3Reliability
If deuterium replaces hydrogen atoms in paraxanthine, then side effects are reduced and duration of action is extended, but manufacturing complexity and cost increase
Solution Approach 1:
Instead of deuterating the entire paraxanthine molecule uniformly, the patent applies deuterium substitution at specific local positions - the methyl groups (C-6 and C-7 positions). This localized deuteration approach maintains the core pharmacological activity of paraxanthine while introducing the beneficial effects of deuterium at key metabolic sites. This selective approach simplifies the manufacturing process compared to complete molecular deuteration while still achieving the desired pharmacological improvements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Deuterated paraxanthine compositions provide a similar central nervous system exposure to non-isotopically enriched paraxanthine while minimizing side effects and increasing the duration of action, thus enhancing patient compliance and ease of use.
Implementation Method 1
Deuterated paraxanthine compositions provide a similar central nervous system exposure to non-isotopically enriched paraxanthine while minimizing side effects and increasing the duration of action
Data Source
AI summary
Provided herein are compositions (e.g., pharmaceutical compositions, nutraceutical compositions, foods, beverages, cosmetic compositions, diet supplements) comprising deuterated paraxanthine. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as obesity, causing weight loss, increasing metabolic rate, reducing appetite, increasing energy expenditure, increasing urine output, increasing sodium excretion, reducing edema, a pain disorder, apnea, hypotension, an encephalopathy, a neurological or psychiatric disorder, and an inflammatory disorder.